Search Results - H.T. Claude Chan

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion by Robert J Oldham, C Ian Mockridge, Sonya James, Patrick J Duriez, H T Claude Chan, Kerry L Cox, Vicentiu A Pitic, Mark S Cragg

    Published in Journal for ImmunoTherapy of Cancer (2020-05-01)
    Get full text
    Article


  2. 2

    Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc by Osman Dadas, Osman Dadas, Joel D. Allen, Sarah L. Buchan, Jinny Kim, H. T. Claude Chan, C. Ian Mockridge, Patrick J. Duriez, Anne Rogel, Max Crispin, Aymen Al-Shamkhani

    Published in Frontiers in Immunology (2023-10-01)
    Get full text
    Article


  3. 3

    Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonism by Isabel G. Elliott, Hayden Fisher, H. T. Claude Chan, Tatyana Inzhelevskaya, C. Ian Mockridge, Christine A. Penfold, Patrick J. Duriez, Christian M. Orr, Julie Herniman, Kri T. J. Müller, Jonathan W. Essex, Mark S. Cragg, Ivo Tews

    Published in Nature Communications (2025-04-01)
    Get full text
    Article


  4. 4

    LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation by Muchaala Yeboah, Charys Papagregoriou, Des C. Jones, H.T. Claude Chan, Guangan Hu, Justine S. McPartlan, Torbjörn Schiött, Ulrika Mattson, C. Ian Mockridge, Ulla-Carin Tornberg, Björn Hambe, Anne Ljungars, Mikael Mattsson, Ivo Tews, Martin J. Glennie, Stephen M. Thirdborough, John Trowsdale, Björn Frendeus, Jianzhu Chen, Mark S. Cragg, Ali Roghanian

    Published in JCI Insight (2020-09-01)
    Get full text
    Article


Search Tools: